Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 204.80
+2.20 (1.09%)
Aug 11, 2026, 11:54 AM HKT
HKG:2637 Market Cap
HKG:2637 has a market cap or net worth of 15.95 billion as of August 10, 2026.
Market Cap
15.95B
Enterprise Value
14.59B
Revenue
648.05M
Ranking
n/a
PE Ratio
71.48
Stock Price
204.80
ChartMarket Cap Chart
Since October 20, 2025, HKG:2637's market cap has increased from 8.20B to 15.95B, an increase of 94.43%. That is a compound annual growth rate of 127.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 15.95B | 48.97% |
| Dec 31, 2025 | 10.70B | 30.52% |
| Oct 20, 2025 | 8.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| China Resources Pharmaceutical Group | 30.41B |
| China Medical System Holdings | 30.01B |
| Sunshine Lake Pharma | 20.42B |
| Grand Pharmaceutical Group | 18.33B |
| The United Laboratories International Holdings | 18.21B |
| Consun Pharmaceutical Group | 11.75B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| CanSino Biologics | 10.50B |